These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 22322899)
21. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A. Ren L; Jing J; Chen G; Miao Y; Wei P J Pharm Pharmacol; 2014 Jul; 66(7):927-34. PubMed ID: 24697809 [TBL] [Abstract][Full Text] [Related]
22. Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma. Michel D; Chitanda JM; Balogh R; Yang P; Singh J; Das U; El-Aneed A; Dimmock J; Verrall R; Badea I Eur J Pharm Biopharm; 2012 Aug; 81(3):548-56. PubMed ID: 22531300 [TBL] [Abstract][Full Text] [Related]
23. A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells. Cutrignelli A; Lopedota A; Denora N; Iacobazzi RM; Fanizza E; Laquintana V; Perrone M; Maggi V; Franco M J Pharm Sci; 2014 Dec; 103(12):3932-3940. PubMed ID: 25302947 [TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin. Lu Y; Zhang T; Tao J; Ji G; Wang S Drug Dev Ind Pharm; 2009 Dec; 35(12):1452-9. PubMed ID: 19929204 [TBL] [Abstract][Full Text] [Related]
25. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Kesharwani P; Xie L; Banerjee S; Mao G; Padhye S; Sarkar FH; Iyer AK Colloids Surf B Biointerfaces; 2015 Dec; 136():413-23. PubMed ID: 26440757 [TBL] [Abstract][Full Text] [Related]
26. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy. Mohanty C; Acharya S; Mohanty AK; Dilnawaz F; Sahoo SK Nanomedicine (Lond); 2010 Apr; 5(3):433-49. PubMed ID: 20394536 [TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization and antitumor activity of a cationic starch-derivative membrane embedded with a β-cyclodextrin/curcumin inclusion complex. Gularte MS; Quadrado RFN; Pedra NS; Soares MSP; Bona NP; Spanevello RM; Fajardo AR Int J Biol Macromol; 2020 Apr; 148():140-152. PubMed ID: 31945443 [TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization and in vitro biological evaluation of (1:2) phenoxodiol-β-cyclodextrin complex. Yee EM; Hook JM; Bhadbhade MM; Vittorio O; Kuchel RP; Brandl MB; Tilley RD; Black DS; Kumar N Carbohydr Polym; 2017 Jun; 165():444-454. PubMed ID: 28363571 [TBL] [Abstract][Full Text] [Related]
29. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery. Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714 [TBL] [Abstract][Full Text] [Related]
30. Novel dipeptide nanoparticles for effective curcumin delivery. Alam S; Panda JJ; Chauhan VS Int J Nanomedicine; 2012; 7():4207-22. PubMed ID: 22915849 [TBL] [Abstract][Full Text] [Related]
31. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity. Jain AS; Date AA; Pissurlenkar RR; Coutinho EC; Nagarsenker MS AAPS PharmSciTech; 2011 Dec; 12(4):1163-75. PubMed ID: 21918921 [TBL] [Abstract][Full Text] [Related]
32. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Bao B; Ali S; Banerjee S; Wang Z; Logna F; Azmi AS; Kong D; Ahmad A; Li Y; Padhye S; Sarkar FH Cancer Res; 2012 Jan; 72(1):335-45. PubMed ID: 22108826 [TBL] [Abstract][Full Text] [Related]
34. [Study on the preparation of curcumin inclusion complex and its stability]. Gao ZS; Fu YX; Wang JD Zhong Yao Cai; 2011 Oct; 34(10):1615-7. PubMed ID: 22372155 [TBL] [Abstract][Full Text] [Related]
35. Characterization of Curcumin/Cyclodextrin Polymer Inclusion Complex and Investigation on Its Antioxidant and Antiproliferative Activities. Chen J; Qin X; Zhong S; Chen S; Su W; Liu Y Molecules; 2018 May; 23(5):. PubMed ID: 29762477 [TBL] [Abstract][Full Text] [Related]
36. Preparation, Characterization and Evaluation of the Anti-Inflammatory Activity of Epichlorohydrin-β-Cyclodextrin/Curcumin Binary Systems Embedded in a Pluronic Fernández-Romero AM; Maestrelli F; García-Gil S; Talero E; Mura P; Rabasco AM; González-Rodríguez ML Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948364 [TBL] [Abstract][Full Text] [Related]
37. Fabrication of β-cyclodextrin-mediated single bimolecular inclusion complex: characterization, molecular docking, in-vitro release and bioavailability studies for gefitinib and simvastatin conjugate. Basak S; Mondal S; Dey S; Bhattacharya P; Saha A; Deep Punetha V; Abbas A; Gopal Sahoo N J Pharm Pharmacol; 2017 Oct; 69(10):1304-1317. PubMed ID: 28631808 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, characterization and anti-tubercular activity of ferrocenyl hydrazones and their β-cyclodextrin conjugates. Dandawate P; Vemuri K; Khan EM; Sritharan M; Padhye S Carbohydr Polym; 2014 Aug; 108():135-44. PubMed ID: 24751257 [TBL] [Abstract][Full Text] [Related]
39. Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin. Horvath G; Premkumar T; Boztas A; Lee E; Jon S; Geckeler KE Mol Pharm; 2008; 5(2):358-63. PubMed ID: 18281942 [TBL] [Abstract][Full Text] [Related]
40. Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Yallapu MM; Jaggi M; Chauhan SC Macromol Biosci; 2010 Oct; 10(10):1141-51. PubMed ID: 20572274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]